Skip to main content

Table 1 Epidemiological and clinical characteristics of cirrhotic patients admitted into Spanish intensive care units between 2005 and 2010

From: Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit

 

Control-group

CHC-group

p-value

No.

4127

1138

 

Males

2737 (66.3 %)

719 (63.2 %)

0.053

Age (years)

57.2 (56.7; 57.6)

58.2 (57.4; 58.9)

0.030

Length of hospital stay (days)

12.5 (11.9; 13.1)

10.7 (9.9; 11.6)

<0.001

Abuse of alcohol and drugs

1622 (39.3 %)

342 (30.1 %)

<0.001

Charlson comorbidity index

0.91 (0.86; 0.95)

0.75 (0.68; 0.82)

<0.001

Decompensated cirrhosis

2539 (61.5 %)

777 (68.3 %)

<0.001

General comorbidities

 Cardiovascular

3041 (73.7 %)

830 (72.9 %)

0.638

 Infectious without hepatitis

1352 (32.8 %)

383 (33.7 %)

0.594

 Respiratory

2212 (53.6 %)

597 (52.5 %)

0.517

 Gastrointestinal/hepatic

4029 (97.6 %)

1105 (97.1 %)

0.368

 Neurological

911 (22.1 %)

263 (23.1 %)

0.482

 Cancer

296 (7.2 %)

93 (8.2 %)

0.281

 Diabetes

692 (16.8 %)

210 (18.5 %)

0.196

  1. Values are expressed as absolute numbers (percentages) and as the mean (95 % confidence intervals). P-values were calculated by the chi-squared test or Student’s t-test, as appropriate
  2. Abbreviation: CHC chronic hepatitis C virus